Personnel

Codon Devices names president and CEO

Published in Gene Therapy Weekly, May 4th, 2006

Codon Devices, the first venture-backed startup in the emerging field of synthetic biology, announced that the company has named John P. Danner as president, chief executive officer, and member of the board of directors.

Danner brings more than 15 years of leadership experience to Codon Devices and joins from PerkinElmer, Inc. (PKI), where he held a number of executive positions including vice president and general manager of a $450 million group of biopharmaceutical tools businesses.

Prior to his six year tenure at PerkinElmer, Danner was a consultant with McKinsey & Company, serving in both the United States and Europe, focusing on strategy...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2006-05-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry